• 1107 Citations
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

Clinical interests: treatment of lung cancer Research interests: predictors of recurrence in patients with early stage non-small cell lung cancer (NSCLC), clinical and molecular predictors of brain metastases in patients with NSCLC, developing novel therapeutics in lung cancer.

Areas of Clinical Interest

lung cancer, esophageal cancer, medical oncology,

Fingerprint Dive into the research topics where Saiama Waqar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Demystifying the Role of Tumor Mutational Burden for Immunotherapy Selection-Reply

Waqar, S. & Govindan, R., 2020, (Accepted/In press) In : JAMA oncology.

Research output: Contribution to journalLetter

Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy

Arnold, S. M., Chansky, K., Baggstrom, M. Q., Thompson, M. A., Sanborn, R. E., Villano, J. L., Waqar, S. N., Hamm, J., Leggas, M., Willis, M., Rosales, J. & Crowley, J. J., Jan 1 2020, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

  • The Mystic Role of Tumor Mutational Burden in Selecting Patients with Lung Cancer for First-Line Immunotherapy

    Waqar, S. N. & Govindan, R., May 2020, In : JAMA oncology. 6, 5, p. 674-675 2 p.

    Research output: Contribution to journalComment/debate

    Association between depth of response and survival in patients with advanced-stage non–small cell lung cancer treated with first-line chemotherapy

    Morgensztern, D., Ko, A., O’Brien, M., Ong, T. J., Waqar, S. N., Socinski, M. A., Postmus, P. E. & Bhore, R., Jul 15 2019, In : Cancer. 125, 14, p. 2394-2399 6 p.

    Research output: Contribution to journalArticle

  • Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)

    Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M. & Lovly, C. M., Apr 2019, In : Annals of Oncology. 30, p. ii48

    Research output: Contribution to journalArticle

    Open Access